Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Company Profile
|
Yakult Honsha Co., Ltd. (Yakult Honsha or 'the company') is a Japan-based company engaged in the manufacturing and marketing of food and beverages, cosmetics, and pharmaceuticals. The company primarily operates in Japan. It is headquartered in Tokyo, Japan, and employed 2,936 people, including 283 temporarily-assigned employees and 147 contract employees, as of March 31, 2012.
Published By MarketLine
|
07 Mar 2013 |
$175
|
Company Profile
|
Wuxi Pharmatech (Cayman) Inc. (WuXi or 'the company') is a leading outsourcing services provider to global pharmaceutical, biopharmaceutical and medical device companies. It offers a range of laboratory and manufacturing services across the discovery-to-commercialization spectrum. The company primarily operates in China and the US. It is headquartered in Shanghai, China and employed 5,689 people as of December 31, 2011.
Published By MarketLine
|
28 Sep 2012 |
$175
|
Company Profile
|
Warner Chilcott Public Limited Company (WCRX or 'the company') is a leading provider of specialty branded pharmaceuticals primarily in women's healthcare, gastroenterology, urology and dermatology segments. The company primarily operates in the US and Western Europe. It is headquartered in Dublin, Ireland, and employed 2,100 people as of December 31, 2012.
Published By MarketLine
|
07 Jun 2013 |
$175
|
Company Profile
|
Vivus (or 'the company') is a biopharmaceutical company focused on research, development and commercialization of products in the areas of sexual health, obesity and diabetes. The company primarily operates in the US. Vivus is headquartered in Mountain View, California, and employed 38 people as of February 17, 2012.
Published By MarketLine
|
18 Jan 2013 |
$175
|
Company Profile
|
ViroPharma Incorporated (ViroPharma or 'the company') is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases. The company operates in the US, Belgium, Canada, France, Italy, Germany, Spain, Switzerland and the UK. It is headquartered in Exton, Pennsylvania and employed 311 people as of December 31, 2011.
Published By MarketLine
|
11 Jan 2013 |
$175
|
Company Profile
|
Virbac Corporation (Virbac or 'the company'), a subsidiary of Virbac SA, is engaged in the business of manufacturing and marketing animal health and pet care products. The company operates in the US where it is headquartered in Fort Worth, Texas. It employed 345 people as of December 31, 2011.
Published By MarketLine
|
13 Dec 2012 |
$175
|
Company Profile
|
Vertex Pharmaceuticals Incorporated (Vertex or 'the company') is a commercial-stage biotechnology company engaged in the discovery, development and commercialization of small molecule drugs for the treatment of major diseases such as viral infections, cystic fibrosis, inflammation, autoimmune disorders and cancer. The company operates in the US. It is headquartered in Cambridge, Massachusetts and employed 2,000 people as of December 31, 2011.
Published By MarketLine
|
28 Aug 2012 |
$175
|
Company Profile
|
Vectura Group (Vectura or 'the group') is engaged in the development of inhaled therapies for the treatment of respiratory diseases. The group operates in the UK, where it is headquartered in Wiltshire. Vectura employed 209 people as of March 31, 2012.
Published By MarketLine
|
07 Mar 2013 |
$175
|
Company Profile
|
United Therapeutics Corporation (United Therapeutics or 'the company') is a biotechnology company focused on the development and commercialization of products for the treatment of patients with cardiovascular and infectious diseases and cancer. The company's principal therapeutic platforms include prostacyclin analogues, phosphodiesterase type 5 (PDE-5) inhibitors, glycobiology antiviral agents and monoclonal antibodies. The company primarily operates in the US, where it is headquartered in Silver Spring,
Published By MarketLine
|
15 Jun 2012 |
$175
|
Industry Profile
|
Essential resource for top-line data and analysis covering the United States pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Published By MarketLine
|
12 Feb 2013 |
$350
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.